FINWIRES · TerminalLIVE
FINWIRES

Revolution Medicines' Drug Shows Survival Benefit in Pancreatic Cancer Trial; Shares Rise Pre-Bell

-- Revolution Medicines (RVMD) said Monday the phase 3 trial of its experimental drug, daraxonrasib, to treat a type of pancreatic cancer met key goals, showing significant improvements in progression-free and overall survival versus standard chemotherapy.

The company said the drug delivered a median overall survival of 13.2 months, compared with 6.7 months for chemotherapy.

The drug developer said it plans to submit the data to global regulators, including the US Food and Drug Administration, for marketing application.

Shares of the company were up over 34% in Monday's premarket activity.

Price: $129.87, Change: $+33.10, Percent Change: +34.32%

Related Articles

Australia

Jefferies Raises Quest Diagnostics Price Target to $225 From $220

Quest Diagnostics (DGX) has an average rating of overweight and mean price target of $219, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $204.33, Change: $+8.02, Percent Change: +4.09%

$DGX
Australia

Truist Securities Cuts Tractor Supply Price Target to $44 From $55, Hold Rating Kept

Tractor Supply (TSCO) has an average rating of overweight and mean price target of $56.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $39.92, Change: $-4.90, Percent Change: -10.92%

$TSCO
Sectors

Sector Update: Energy

Energy stocks were higher Tuesday afternoon, with the NYSE Energy Sector Index rising 1.1% and the State Street Energy Select Sector SPDR ETF (XLE) adding 1.2%.The Philadelphia Oil Service Sector Index was climbing 1.8%, while the Dow Jones US Utilities Index fell 1.3%.Front-month West Texas Intermediate crude oil was rising 4.8% to $93.94 a barrel, and the global benchmark Brent crude contract was advancing 4.4% to $99.68 a barrel. Henry Hub natural gas futures increased 0.3% to $2.70 per 1 million BTU.In corporate news, Halliburton (HAL) shares gained 4.1% after it reported lower Q1 adjusted net income and revenue that still topped analysts' expectations.

$HAL